Clinical characteristics and antibiotic susceptibility of viridans streptococcal bacteremia in children with febrile neutropenia

Infection

Volumn 41, Issue 5, 2013, Pages 917-924

  Han, S B ^a   Bae, E Y ^a   Lee, J W ^a   Lee, D G ^a   Chung, N G ^a   Jeong, D C ^a   Cho, B ^a   Kang, J H ^a   Kim, H K ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Bacteremia; Child; Neutropenia; Viridans streptococci

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; CEFEPIME; CEFOTAXIME; CLINDAMYCIN; COTRIMOXAZOLE; CYTARABINE; DALFOPRISTIN PLUS QUINUPRISTIN; GLYCOPEPTIDE; ISEPAMICIN; LINEZOLID; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINUPRISTIN; TEICOPLANIN; TRIMETHOPRIM; VANCOMYCIN;

ABDOMINAL PAIN; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; APLASTIC ANEMIA; ARTICLE; BLOOD CULTURE; CENTRAL VENOUS CATHETER; CHILD; CHILD DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CORYNEBACTERIUM INFECTION; DIARRHEA; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI INFECTION; FEBRILE NEUTROPENIA; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEMOPHAGOCYTIC SYNDROME; HUMAN; HYPOXIA; INCIDENCE; LABORATORY TEST; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MALE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NEUTROPENIA; NEUTROPHIL COUNT; ORAL MUCOSITIS; OXYGEN THERAPY; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SCHOOL CHILD; SEPTIC SHOCK; STEM CELL TRANSPLANTATION; STREPTOCOCCUS VIRIDANS INFECTION; SYMPTOMATOLOGY; TREATMENT DURATION; VIRIDANS STREPTOCOCCAL BACTEREMIA; VOMITING;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; FEBRILE NEUTROPENIA; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; ROC CURVE; STREPTOCOCCAL INFECTIONS; VIRIDANS STREPTOCOCCI; YOUNG ADULT;

EID: 84885185171     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-013-0470-7     Document Type: Article

References (30)

1. Elting LS, Rubenstein EB, Rolston KV, Bodey GP. Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis. 1997;25:247-59.
2. Castagnola E, Fontana V, Caviglia I, et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis. 2007;45:1296-304.
3. Ko EY, Kang HJ, Kwon HJ, et al. Clinical investigation of bacteremia in children with hemato-oncologic diseases. Infect Chemother. 2011;43:191-7.
4. Lee HJ, Lee JW, Kim JH, et al. A survey for causative organisms and antimicrobial susceptibilities of bacteremia in a single center children with hemato-oncologic diseases (2004-2006). Clin Pediatr Hematol Oncol. 2008;15:65-74.
5. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. Clin Infect Dis. 1999;29:490-4.
6. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2011;52:e56-93.
7. Lee DG, Kim SH, Kim SY, et al. Evidence-based guidelines for empirical therapy of neutropenic fever in Korea. Korean J Intern Med. 2011;26:220-52.
8. Hakim H, Flynn PM, Knapp KM, Srivastava DK, Gaur AH. Etiology and clinical course of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol. 2009;31:623-9.
9. Bruckner L, Gigliotti F. Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance. Semin Pediatr Infect Dis. 2006;17:153-60.
10. Husain E, Whitehead S, Castell A, Thomas EE, Speert DP. Viridans streptococci bacteremia in children with malignancy: relevance of species identification and penicillin susceptibility. Pediatr Infect Dis J. 2005;24:563-6.
11. Marron A, Carratalà J, González-Barca E, Fernández-Sevilla A, Alcaide F, Gudiol F. Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer. Clin Infect Dis. 2000;31:1126-30.
12. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet. 2007;369:1553-64.
13. Gassas A, Grant R, Richardson S, et al. Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients. J Clin Oncol. 2004;22:1222-7.
14. Paganini H, Staffolani V, Zubizarreta P, Casimir L, Lopardo H, Luppino V. Viridans streptococci bacteraemia in children with fever and neutropenia: a case-control study of predisposing factors. Eur J Cancer. 2003;39:1284-9.
15. Richard P, Amador Del Valle G, Moreau P, et al. Viridans streptococcal bacteraemia in patients with neutropenia. Lancet. 1995;345:1607-9.
16. Rossetti F, Cesaro S, Putti MC, Zanesco L. High-dose cytosine arabinoside and viridans Streptococcus sepsis in children with leukemia. Pediatr Hematol Oncol. 1995;12:387-92.
17. Tunkel AR, Sepkowitz KA. Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis. 2002;34:1524-9.
18. Reilly AF, Lange BJ. Infections with viridans group streptococci in children with cancer. Pediatr Blood Cancer. 2007;49:774-80.
19. Ahmed R, Hassall T, Morland B, Gray J. Viridans Streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem. Pediatr Hematol Oncol. 2003;20:439-44.
20. Spanik S, Trupl J, Kunova A, et al. Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis. Scand J Infect Dis. 1997;29:245-9.
21. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448-54.
22. Engel A, Kern P, Kern WV. Levels of cytokines and cytokine inhibitors in the neutropenic patient with alpha-hemolytic Streptococcus shock syndrome. Clin Infect Dis. 1996;23:785-9.
23. Ihendyane N, Sparrelid E, Wretlind B, et al. Viridans streptococcal septicaemia in neutropenic patients: role of proinflammatory cytokines. Bone Marrow Transplant. 2004;33:79-85.
24. Soto A, McWhinney PH, Kibbler CC, Cohen J. Cytokine release and mitogenic activity in the viridans streptococcal shock syndrome. Cytokine. 1998;10:370-6.
25. Ward MA, Lentzsch-Parcells CL. Fever: pathogenesis and treatment. In: Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL, editors. Feigin and Cherry's textbook of pediatric infectious diseases. 6th ed. Philadelphia: Saunders; 2009. p. 105-10.
26. Han XY, Kamana M, Rolston KV. Viridans streptococci isolated by culture from blood of cancer patients: clinical and microbiologic analysis of 50 cases. J Clin Microbiol. 2006;44:160-5.
27. Karp JE, Dick JD, Angelopulos C, et al. Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia. Am J Med. 1986;81:237-42.
28. Paul M, Borok S, Fraser A, Vidal L, Leibovici L. Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2005;55:436-44.
29. Ramphal R. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis. 2004;39(Suppl 1):S25-31.
30. Rubin M, Hathorn JW, Marshall D, Gress J, Steinberg SM, Pizzo PA. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Ann Intern Med. 1988;108:30-5.